Clinical Issues Related to the Costs of Alcoholism
| Autor: | Robert W. McGuffin, Matthew O. Howard, Andrew J. Saxon, R. Dale Walker, Kevin L. Sloan |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
medicine.medical_specialty
Cost effectiveness Alcohol Naltrexone chemistry.chemical_compound Cost of Illness Humans Medicine Psychiatry health care economics and organizations Pharmacology Health economics business.industry Health Policy Public health Alcohol dependence Public Health Environmental and Occupational Health medicine.disease United States Substance Withdrawal Syndrome Alcoholism chemistry Alcohol withdrawal syndrome Disulfiram business Alcohol Deterrents medicine.drug |
| Zdroj: | PharmacoEconomics. 9:134-145 |
| ISSN: | 1170-7690 |
| DOI: | 10.2165/00019053-199609020-00005 |
| Popis: | Alcohol (ethanol) use disorders are prevalent in many countries and are associated with significant social and health costs. Little is known, however, about the comparative cost effectiveness of treatments for alcoholism. Pharmacoeconomic evaluations are largely (if not wholly) absent from the alcoholism treatment outcome database. We discuss pharmacological approaches to the treatment of alcohol withdrawal and dependence, describing agents that ameliorate withdrawal symptoms, deter alcohol consumption, reduce alcohol craving and produce conditioned alcohol aversion. Cost-relevant clinical considerations are elucidated and recommendations for cost-conscious pharmacological treatment of alcohol dependence are proffered. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink